首页> 外文期刊>Cancer research: The official organ of the American Association for Cancer Research, Inc >ROR gamma t(+) Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers
【24h】

ROR gamma t(+) Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers

机译:RORγt(+)先天淋巴细胞促进乳腺癌的淋巴结转移

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cancer cells tend to metastasize first to tumor-draining lymph nodes, but the mechanisms mediating cancer cell invasion into the lymphatic vasculature remain little understood. Here, we show that in the human breast tumor microenvironment (TME), the presence of increased numbers of ROR gamma t(+) group 3 innate lymphoid cells (ILC3) correlates with an increased likelihood of lymph node metastasis. In a preclinical mouse model of breast cancer, CCL21-mediated recruitment of ILC3 to tumors stimulated the production of the CXCL13 by TME stromal cells, which in turn promoted ILC3-stromal interactions and production of the cancer cell motile factor RANKL. Depleting ILC3 or neutralizing CCL21, CXCL13, or RANKL was sufficient to decrease lymph node metastasis. Our findings establish a role for ROR gamma t(+)ILC3 in promoting lymphatic metastasis by modulating the local chemokine milieu of cancer cells in the TME. (C) 2017 AACR.
机译:癌细胞倾向于转移至肿瘤排水淋巴结,但介导癌细胞侵袭到淋巴脉管系统的机制仍然很少理解。 在这里,我们表明,在人乳腺肿瘤微环境(TME)中,ROLγT(+)第3组先天淋巴细胞(ILC3)的增加与淋巴结转移的可能性增加相关。 在乳腺癌的临床型小鼠模型中,CCL21介导ILC3对肿瘤的募集刺激了TME基质细胞的CXCL13的产生,这反过来促进了ILC3 - 基质相互作用和产生了癌细胞运动因子RANKL。 耗尽ILC 3或中和CCL21,CXCL13或RANKL足以降低淋巴结转移。 我们的研究结果建立了RORγT(+)ILC3通过调节TME中癌细胞的当地趋化因子Milieu来促进淋巴结转移的作用。 (c)2017年AACR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号